http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2003020312-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
filingDate | 2002-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2004-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2003020312-A1 |
titleOfInvention | Agent for ischemic heart failure |
abstract | The present inventors have been in the process of diligently searching for a drug that improves survival in ischemic heart failure, particularly heart failure after myocardial infarction, βARK1 inhibitor βARKct is not only a heart function improving effect on heart failure after myocardial infarction, It was found to have a survival rate improving effect. Therefore, the βARK1 inhibitor is used as an effective therapeutic agent for ischemic heart failure having not only a cardiac function improving effect but also a survival rate improving effect, and it is greatly expected that the βARK1 inhibitor will lead to improvement of the prognosis of patients with ischemic heart failure. |
priorityDate | 2001-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 617.